chrX-24498862-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_005391.5(PDK3):āc.282T>Cā(p.Tyr94=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000737 in 1,152,887 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 32 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.000092 ( 0 hom., 3 hem., cov: 21)
Exomes š: 0.000072 ( 0 hom. 29 hem. )
Consequence
PDK3
NM_005391.5 synonymous
NM_005391.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.172
Genes affected
PDK3 (HGNC:8811): (pyruvate dehydrogenase kinase 3) The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2). It provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle, and thus is one of the major enzymes responsible for the regulation of glucose metabolism. The enzymatic activity of PDH is regulated by a phosphorylation/dephosphorylation cycle, and phosphorylation results in inactivation of PDH. The protein encoded by this gene is one of the three pyruvate dehydrogenase kinases that inhibits the PDH complex by phosphorylation of the E1 alpha subunit. This gene is predominantly expressed in the heart and skeletal muscles. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant X-24498862-T-C is Benign according to our data. Variant chrX-24498862-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 541115.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.172 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDK3 | NM_005391.5 | c.282T>C | p.Tyr94= | synonymous_variant | 3/11 | ENST00000379162.9 | NP_005382.1 | |
PDK3 | NM_001142386.3 | c.282T>C | p.Tyr94= | synonymous_variant | 3/12 | NP_001135858.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDK3 | ENST00000379162.9 | c.282T>C | p.Tyr94= | synonymous_variant | 3/11 | 1 | NM_005391.5 | ENSP00000368460 | P1 | |
PDK3 | ENST00000568479.2 | c.282T>C | p.Tyr94= | synonymous_variant | 3/12 | ENSP00000498864 | ||||
PDK3 | ENST00000493226.2 | n.494T>C | non_coding_transcript_exon_variant | 3/3 | 5 | |||||
PDK3 | ENST00000648777.1 | c.282T>C | p.Tyr94= | synonymous_variant, NMD_transcript_variant | 3/12 | ENSP00000497727 |
Frequencies
GnomAD3 genomes AF: 0.0000916 AC: 10AN: 109179Hom.: 0 Cov.: 21 AF XY: 0.0000952 AC XY: 3AN XY: 31513
GnomAD3 genomes
AF:
AC:
10
AN:
109179
Hom.:
Cov.:
21
AF XY:
AC XY:
3
AN XY:
31513
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000154 AC: 24AN: 156082Hom.: 0 AF XY: 0.000218 AC XY: 11AN XY: 50420
GnomAD3 exomes
AF:
AC:
24
AN:
156082
Hom.:
AF XY:
AC XY:
11
AN XY:
50420
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000719 AC: 75AN: 1043708Hom.: 0 Cov.: 21 AF XY: 0.0000893 AC XY: 29AN XY: 324814
GnomAD4 exome
AF:
AC:
75
AN:
1043708
Hom.:
Cov.:
21
AF XY:
AC XY:
29
AN XY:
324814
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000916 AC: 10AN: 109179Hom.: 0 Cov.: 21 AF XY: 0.0000952 AC XY: 3AN XY: 31513
GnomAD4 genome
AF:
AC:
10
AN:
109179
Hom.:
Cov.:
21
AF XY:
AC XY:
3
AN XY:
31513
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Charcot-Marie-Tooth disease X-linked dominant 6 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at